<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Planning for, conducting and reporting a single case experimental design</title>
    <meta charset="utf-8" />
    <meta name="author" content="University of Sheffield" />
    <link href="libs/remark-css/default.css" rel="stylesheet" />
    <link href="libs/remark-css/default-fonts.css" rel="stylesheet" />
    <link href="libs/remark-css/hygge.css" rel="stylesheet" />
    <script type="application/json" id="xaringanExtra-editable-docid">{"id":"x44f80c76f0049f585984442a1e1acf0","expires":14}</script>
    <script src="libs/himalaya/himalaya.js"></script>
    <script src="libs/js-cookie/js.cookie.js"></script>
    <link href="libs/editable/editable.css" rel="stylesheet" />
    <script src="libs/editable/editable.js"></script>
    <link href="libs/panelset/panelset.css" rel="stylesheet" />
    <script src="libs/panelset/panelset.js"></script>
    <script src="libs/freezeframe/freezeframe.min.js"></script>
    <script src="libs/xaringanExtra-freezeframe/freezeframe-init.js"></script>
    <script id="xaringanExtra-freezeframe-options" type="application/json">{"selector":"img[src$=\"gif\"]","trigger":"click","overlay":false,"responsive":true,"warnings":true}</script>
    <script src="libs/xaringanExtra-webcam/webcam.js"></script>
    <script id="xaringanExtra-webcam-options" type="application/json">{"width":"200","height":"200","margin":"1em"}</script>
    <script src="libs/xaringanExtra_fit-screen/fit-screen.js"></script>
    <script src="libs/xaringanExtra-progressBar/progress-bar.js"></script>
    <link href="libs/tile-view/tile-view.css" rel="stylesheet" />
    <script src="libs/tile-view/tile-view.js"></script>
    <script src="libs/fabric/fabric.min.js"></script>
    <link href="libs/xaringanExtra-scribble/scribble.css" rel="stylesheet" />
    <script src="libs/xaringanExtra-scribble/scribble.js"></script>
    <script>document.addEventListener('DOMContentLoaded', function() { window.xeScribble = new Scribble({"pen_color":["#FF0000"],"pen_size":3,"eraser_size":30,"palette":[]}) })</script>
    <script src="libs/kePrint/kePrint.js"></script>
    <link href="libs/lightable/lightable.css" rel="stylesheet" />
    <link rel="stylesheet" href="custom.css" type="text/css" />
    <link rel="stylesheet" href="fonts.css" type="text/css" />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/animate.css/3.7.0/animate.min.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: top, center, title-slide

# Planning for, conducting and reporting a single case experimental design
## Clinical and Applied Psychology Unit
### University of Sheffield

---



class: center, middle, split-three, about-me-slide
background-image: url(uos.png), url(pearls.jpg)
background-position:5% 95%, 98% 96%
background-size: 110px 50px, 10%

.column.bg-main1[.content[
&lt;img style="border-radius: 50%;" src="https://catalyse.uk.com/wp-content/uploads/sites/3/2015/10/SKcrop.jpg" width="150px"/&gt;

### Steve Kellett

#### Clinical Psychologist

.fade[Sheffied Health &amp; Social Care
NHS Foundation Trust]

[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"&gt;&lt;/path&gt;&lt;/svg&gt;](mailto:s.kellett@sheffield.ac.uk)
[&lt;svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://www.researchgate.net/profile/Stephen-Kellett)
]]
.column.bg-main2[.content[
&lt;img style="border-radius: 50%;" src="https://pbs.twimg.com/profile_images/1235537191683723265/Qo6rZ317_400x400.jpg" width="150px"/&gt;

### Mel Simmonds-Buckley

#### Researcher

.fade[University of Sheffield]

[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"&gt;&lt;/path&gt;&lt;/svg&gt;](mailto:m.simmonds-buckley@sheffield.ac.uk)
[&lt;svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M622.34 153.2L343.4 67.5c-15.2-4.67-31.6-4.67-46.79 0L17.66 153.2c-23.54 7.23-23.54 38.36 0 45.59l48.63 14.94c-10.67 13.19-17.23 29.28-17.88 46.9C38.78 266.15 32 276.11 32 288c0 10.78 5.68 19.85 13.86 25.65L20.33 428.53C18.11 438.52 25.71 448 35.94 448h56.11c10.24 0 17.84-9.48 15.62-19.47L82.14 313.65C90.32 307.85 96 298.78 96 288c0-11.57-6.47-21.25-15.66-26.87.76-15.02 8.44-28.3 20.69-36.72L296.6 284.5c9.06 2.78 26.44 6.25 46.79 0l278.95-85.7c23.55-7.24 23.55-38.36 0-45.6zM352.79 315.09c-28.53 8.76-52.84 3.92-65.59 0l-145.02-44.55L128 384c0 35.35 85.96 64 192 64s192-28.65 192-64l-14.18-113.47-145.03 44.56z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://scholar.google.com/citations?user=T85W7TYAAAAJ&amp;hl=en)
[&lt;svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://www.researchgate.net/profile/Mel-Simmonds-Buckley)
]]
.column.bg-main3[.content[
&lt;img style="border-radius: 50%;" src="https://pbs.twimg.com/profile_images/1371177930236293126/Sf9QTdef_400x400.jpg" width="150px"/&gt;

### Chris Gaskell

#### Clinical Psychologist

.fade[Salford Royal
NHS Foundation Trust]

[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"&gt;&lt;/path&gt;&lt;/svg&gt; ](https://twitter.com/chrisgaskell92)
[&lt;svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://github.com/chris-gaskell)
[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"&gt;&lt;/path&gt;&lt;/svg&gt;](mailto:cgaskell1@sheffield.ac.uk)
[&lt;svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M622.34 153.2L343.4 67.5c-15.2-4.67-31.6-4.67-46.79 0L17.66 153.2c-23.54 7.23-23.54 38.36 0 45.59l48.63 14.94c-10.67 13.19-17.23 29.28-17.88 46.9C38.78 266.15 32 276.11 32 288c0 10.78 5.68 19.85 13.86 25.65L20.33 428.53C18.11 438.52 25.71 448 35.94 448h56.11c10.24 0 17.84-9.48 15.62-19.47L82.14 313.65C90.32 307.85 96 298.78 96 288c0-11.57-6.47-21.25-15.66-26.87.76-15.02 8.44-28.3 20.69-36.72L296.6 284.5c9.06 2.78 26.44 6.25 46.79 0l278.95-85.7c23.55-7.24 23.55-38.36 0-45.6zM352.79 315.09c-28.53 8.76-52.84 3.92-65.59 0l-145.02-44.55L128 384c0 35.35 85.96 64 192 64s192-28.65 192-64l-14.18-113.47-145.03 44.56z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://scholar.google.com/citations?user=gQuNwfYAAAAJ&amp;hl=en&amp;authuser=1&amp;oi=ao)
[&lt;svg viewBox="0 0 448 512" style="position:relative;display:inline-block;top:.1em;height:1.5em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M0 32v448h448V32H0zm262.2 334.4c-6.6 3-33.2 6-50-14.2-9.2-10.6-25.3-33.3-42.2-63.6-8.9 0-14.7 0-21.4-.6v46.4c0 23.5 6 21.2 25.8 23.9v8.1c-6.9-.3-23.1-.8-35.6-.8-13.1 0-26.1.6-33.6.8v-8.1c15.5-2.9 22-1.3 22-23.9V225c0-22.6-6.4-21-22-23.9V193c25.8 1 53.1-.6 70.9-.6 31.7 0 55.9 14.4 55.9 45.6 0 21.1-16.7 42.2-39.2 47.5 13.6 24.2 30 45.6 42.2 58.9 7.2 7.8 17.2 14.7 27.2 14.7v7.3zm22.9-135c-23.3 0-32.2-15.7-32.2-32.2V167c0-12.2 8.8-30.4 34-30.4s30.4 17.9 30.4 17.9l-10.7 7.2s-5.5-12.5-19.7-12.5c-7.9 0-19.7 7.3-19.7 19.7v26.8c0 13.4 6.6 23.3 17.9 23.3 14.1 0 21.5-10.9 21.5-26.8h-17.9v-10.7h30.4c0 20.5 4.7 49.9-34 49.9zm-116.5 44.7c-9.4 0-13.6-.3-20-.8v-69.7c6.4-.6 15-.6 22.5-.6 23.3 0 37.2 12.2 37.2 34.5 0 21.9-15 36.6-39.7 36.6z"&gt;&lt;/path&gt;&lt;/svg&gt;](https://www.researchgate.net/profile/Chris-Gaskell-2)
]]

---
class: center, top, split-three, inverse
background-image: url(https://rin.org.uk/resource/resmgr/nav21/nav21_map.png)
background-position:8% 70%
background-size: 375px 300px


.column.bg-main1[.content[.right[
&lt;img style="border-radius: 50%;" src=" " width="150px"/&gt;


# &lt;svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M347.94 129.86L203.6 195.83a31.938 31.938 0 0 0-15.77 15.77l-65.97 144.34c-7.61 16.65 9.54 33.81 26.2 26.2l144.34-65.97a31.938 31.938 0 0 0 15.77-15.77l65.97-144.34c7.61-16.66-9.54-33.81-26.2-26.2zm-77.36 148.72c-12.47 12.47-32.69 12.47-45.16 0-12.47-12.47-12.47-32.69 0-45.16 12.47-12.47 32.69-12.47 45.16 0 12.47 12.47 12.47 32.69 0 45.16zM248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm0 448c-110.28 0-200-89.72-200-200S137.72 56 248 56s200 89.72 200 200-89.72 200-200 200z"&gt;&lt;/path&gt;&lt;/svg&gt; Navigating these slides

]]]

--

.column.bg-main2[.content[
&lt;img style="border-radius: 50%;" src=" " width="150px"/&gt;

.Large[.bold[
### Day 1
[Aims + Intro](#aims-slide)

[Why](#why-slide)

[Measures](#measures-slide)

[Designs](#designs-slide)

[Setting it up](#stages-slide)]
]]]

--

.column.bg-main3[.content[
&lt;img style="border-radius: 50%;" src=" " width="150px"/&gt;

.Large[.Bold[
### Day 2

.bold[
[Analysis](#analysis-slide)

[Practice](#practice-slide)

[Resources](#resources-slide)]

]]]]

--

.footnote[.Large[**Note**: all underlined
.white[.underline[white]] and
.my-hot-white[.my-blue[.underline[blue]]] text are hyperlinks!]
]

---

name: contents-slide
class: inverse
background-image:
background-position:
background-size:

# &lt;svg viewBox="0 0 496 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M347.94 129.86L203.6 195.83a31.938 31.938 0 0 0-15.77 15.77l-65.97 144.34c-7.61 16.65 9.54 33.81 26.2 26.2l144.34-65.97a31.938 31.938 0 0 0 15.77-15.77l65.97-144.34c7.61-16.66-9.54-33.81-26.2-26.2zm-77.36 148.72c-12.47 12.47-32.69 12.47-45.16 0-12.47-12.47-12.47-32.69 0-45.16 12.47-12.47 32.69-12.47 45.16 0 12.47 12.47 12.47 32.69 0 45.16zM248 8C111.03 8 0 119.03 0 256s111.03 248 248 248 248-111.03 248-248S384.97 8 248 8zm0 448c-110.28 0-200-89.72-200-200S137.72 56 248 56s200 89.72 200 200-89.72 200-200 200z"&gt;&lt;/path&gt;&lt;/svg&gt; Navigating these slides

&lt;svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M528 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h480c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm8 336c0 4.411-3.589 8-8 8H48c-4.411 0-8-3.589-8-8V112c0-4.411 3.589-8 8-8h480c4.411 0 8 3.589 8 8v288zM170 270v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm-336 82v-28c0-6.627-5.373-12-12-12H82c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm384 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zM122 188v-28c0-6.627-5.373-12-12-12H82c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm96 0v-28c0-6.627-5.373-12-12-12h-28c-6.627 0-12 5.373-12 12v28c0 6.627 5.373 12 12 12h28c6.627 0 12-5.373 12-12zm-98 158v-16c0-6.627-5.373-12-12-12H180c-6.627 0-12 5.373-12 12v16c0 6.627 5.373 12 12 12h216c6.627 0 12-5.373 12-12z"&gt;&lt;/path&gt;&lt;/svg&gt;
.large[.white[Keyoard shortcuts] - Press 'h'.]

&lt;svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M288 0c-69.59 0-126 56.41-126 126 0 56.26 82.35 158.8 113.9 196.02 6.39 7.54 17.82 7.54 24.2 0C331.65 284.8 414 182.26 414 126 414 56.41 357.59 0 288 0zm0 168c-23.2 0-42-18.8-42-42s18.8-42 42-42 42 18.8 42 42-18.8 42-42 42zM20.12 215.95A32.006 32.006 0 0 0 0 245.66v250.32c0 11.32 11.43 19.06 21.94 14.86L160 448V214.92c-8.84-15.98-16.07-31.54-21.25-46.42L20.12 215.95zM288 359.67c-14.07 0-27.38-6.18-36.51-16.96-19.66-23.2-40.57-49.62-59.49-76.72v182l192 64V266c-18.92 27.09-39.82 53.52-59.49 76.72-9.13 10.77-22.44 16.95-36.51 16.95zm266.06-198.51L416 224v288l139.88-55.95A31.996 31.996 0 0 0 576 426.34V176.02c0-11.32-11.43-19.06-21.94-14.86z"&gt;&lt;/path&gt;&lt;/svg&gt;
.large[.white[Overview slides] - Press 'o'.]

&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M290.74 93.24l128.02 128.02-277.99 277.99-114.14 12.6C11.35 513.54-1.56 500.62.14 485.34l12.7-114.22 277.9-277.88zm207.2-19.06l-60.11-60.11c-18.75-18.75-49.16-18.75-67.91 0l-56.55 56.55 128.02 128.02 56.55-56.55c18.75-18.76 18.75-49.16 0-67.91z"&gt;&lt;/path&gt;&lt;/svg&gt;
.large[.white[Scribble on slides] - Press 's'.]

.footnote[
.Large[&lt;svg viewBox="0 0 384 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M369.9 97.9L286 14C277 5 264.8-.1 252.1-.1H48C21.5 0 0 21.5 0 48v416c0 26.5 21.5 48 48 48h288c26.5 0 48-21.5 48-48V131.9c0-12.7-5.1-25-14.1-34zM332.1 128H256V51.9l76.1 76.1zM48 464V48h160v104c0 13.3 10.7 24 24 24h104v288H48zm250.2-143.7c-12.2-12-47-8.7-64.4-6.5-17.2-10.5-28.7-25-36.8-46.3 3.9-16.1 10.1-40.6 5.4-56-4.2-26.2-37.8-23.6-42.6-5.9-4.4 16.1-.4 38.5 7 67.1-10 23.9-24.9 56-35.4 74.4-20 10.3-47 26.2-51 46.2-3.3 15.8 26 55.2 76.1-31.2 22.4-7.4 46.8-16.5 68.4-20.1 18.9 10.2 41 17 55.8 17 25.5 0 28-28.2 17.5-38.7zm-198.1 77.8c5.1-13.7 24.5-29.5 30.4-35-19 30.3-30.4 35.7-30.4 35zm81.6-190.6c7.4 0 6.7 32.1 1.8 40.8-4.4-13.9-4.3-40.8-1.8-40.8zm-24.4 136.6c9.7-16.9 18-37 24.7-54.7 8.3 15.1 18.9 27.2 30.1 35.5-20.8 4.3-38.9 13.1-54.8 19.2zm131.6-5s-5 6-37.3-7.8c35.1-2.6 40.9 5.4 37.3 7.8z"&gt;&lt;/path&gt;&lt;/svg&gt;]
This presentation is also available as a &lt;a href="https://chris-gaskell.github.io/uos-sced/output/index.pdf"&gt;pdf&lt;/a&gt;.


.Large[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-yellow);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M464 64H48C21.49 64 0 85.49 0 112v288c0 26.51 21.49 48 48 48h416c26.51 0 48-21.49 48-48V112c0-26.51-21.49-48-48-48zm0 48v40.805c-22.422 18.259-58.168 46.651-134.587 106.49-16.841 13.247-50.201 45.072-73.413 44.701-23.208.375-56.579-31.459-73.413-44.701C106.18 199.465 70.425 171.067 48 152.805V112h416zM48 400V214.398c22.914 18.251 55.409 43.862 104.938 82.646 21.857 17.205 60.134 55.186 103.062 54.955 42.717.231 80.509-37.199 103.053-54.947 49.528-38.783 82.032-64.401 104.947-82.653V400H48z"&gt;&lt;/path&gt;&lt;/svg&gt;]
If you find any problems with these slides then e-mail
&lt;a href="mailto:cgaskell1@sheffield.ac.uk"&gt;Chris&lt;/a&gt;.
]

--
.pull-right[
.center[
&lt;figure&gt;
  &lt;img src="https://spcanelon.github.io/xaringan-basics-and-beyond/slides/img/hex-xaringan.png" alt="Trulli" style="width:45%"&gt;
  
    &lt;img src="https://psyteachr.github.io/hack-your-data/img/rmarkdown.png" alt="Trulli" style="width:45%"&gt;
  &lt;figcaption&gt;.small[Slides made using Xaringan and R Markdown.]&lt;/figcaption&gt;
&lt;/figure&gt;

]]


---
layout: true
background-image: url(uos.png), url(pearls.jpg)
background-position:5% 95%, 98% 96%
background-size: 110px 50px, 10%
---
name: aims-slide

#  Aims of the workshop

+ Become .blue[familiar] with the requirements of the SCED.
+ Appreciate links between .blue[practice-based evidence] and SCED methodology.
+ To .blue[understand] the basic features of the available designs.
+ To consider ways of engaging clients in SCED.
+ To appreciate the .blue[potential] of SCED methodology.


---
#  Aims of the workshop

+ .blue[Review the application] of SCED methodology within clinical research and practice.
+ Consider potential .blue[practical difficulties] in implementation of SCED.
+ Provide .blue[practical experience] of design and analysis.
+ Foresee potential difficulties and .blue[trouble-shoot].

---
#  Hopes for the workshop

## Include &lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:grey;height:0.8em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M290.74 93.24l128.02 128.02-277.99 277.99-114.14 12.6C11.35 513.54-1.56 500.62.14 485.34l12.7-114.22 277.9-277.88zm207.2-19.06l-60.11-60.11c-18.75-18.75-49.16-18.75-67.91 0l-56.55 56.55 128.02 128.02 56.55-56.55c18.75-18.76 18.75-49.16 0-67.91z"&gt;&lt;/path&gt;&lt;/svg&gt;
.can-edit.key-firstSlideTitleunique[
- Write 
- Here
- And
- We
- Will
- Come
- Back
]

---
#  A note on the assignment

.pull-left[
+ Conduct a SCED of psychological treatment.
+ Any design is permissible (we will teach you all the methods). 
+ Submit via Unidrive (not Turnitin).
+ Ethical approval for this in place
+ Patient information &amp; consent forms on MUSE (for your appendix).
]


.pull-right[&lt;img src="https://i.imgflip.com/2f6v9k.jpg" alt="Trulli" alt="Girl in a jacket" width="75%" height="75%"&gt;
]

---
layout: false
class: inverse, middle, center
# Introduction to SCED

---
layout: true
name:aims-slide
background-image: url(uos.png), url(pearls.jpg)
background-position:5% 95%, 98% 96%
background-size: 110px 50px, 10%

---
# Brief history slide

---
background-image: url(images/plot.png)
background-position:50% 95%
background-size: 70% 30%

#  Single case involves: 

--

+ .blue[Time-series] measurement (quantifiable + over time).

--

+ .blue[Baseline] period.

--

+ .blue[Experimental manipulation] of an IV.

???

+ (i.e., introduce/remove/change treatment).
+ Experimental = 3+ manipulations
+ Less than this = quasi experimental.

--

+ Focus on .blue[within-subject] variability.

---

#  What is a baseline? 

+ .blue[Repeated measurements] before treatment is introduced.

???

so that the ‘natural course’ of the outcome is known.

--

+ The ideal is .blue[long and stable] baselines.

--

.pull-left[
.red[However:]
+ Not common 
+ Some disorders have inbuilt variability.
+ Are neutral baselines are a fallacy?
]

???
- so don’t always expect a stable baseline
- you have contact with the service user; you are assessing them.
--

.pull-right[
&lt;img src="https://media.makeameme.org/created/one-does-not-5ac35f.jpg" alt="Girl in a jacket" width="370" height="300"&gt;
]

---

#  The focus? 

+ Your .blue[individual] service user.
+ .blue[You], the clinician.
+ Why and what leads to change in this client?
+ Within client change rather than across client change.

---
name: why-slide
class: inverse, middle, center
layout: false

# Why use SCEDs? 


---
layout: true
background-image: url(uos.png), url(pearls.jpg)
background-position:5% 95%, 98% 96%
background-size: 110px 50px, 10%
---

#  So why use SCEDs? 

--

.large[.red[&lt;svg viewBox="0 0 512 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M160 320h12v16c0 8.84 7.16 16 16 16h40c8.84 0 16-7.16 16-16v-16h12c17.67 0 32-14.33 32-32V64c0-17.67-14.33-32-32-32V16c0-8.84-7.16-16-16-16h-64c-8.84 0-16 7.16-16 16v16c-17.67 0-32 14.33-32 32v224c0 17.67 14.33 32 32 32zm304 128h-1.29C493.24 413.99 512 369.2 512 320c0-105.88-86.12-192-192-192v64c70.58 0 128 57.42 128 128s-57.42 128-128 128H48c-26.51 0-48 21.49-48 48 0 8.84 7.16 16 16 16h480c8.84 0 16-7.16 16-16 0-26.51-21.49-48-48-48zm-360-32h208c4.42 0 8-3.58 8-8v-16c0-4.42-3.58-8-8-8H104c-4.42 0-8 3.58-8 8v16c0 4.42 3.58 8 8 8z"&gt;&lt;/path&gt;&lt;/svg&gt; **Clinical research:**] Testing clinical hypotheses and contributing to knowledge.]

--

.large[.blue[&lt;svg viewBox="0 0 480 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M477.7 186.1L309.5 18.3c-3.1-3.1-8.2-3.1-11.3 0l-34 33.9c-3.1 3.1-3.1 8.2 0 11.3l11.2 11.1L33 316.5c-38.8 38.7-45.1 102-9.4 143.5 20.6 24 49.5 36 78.4 35.9 26.4 0 52.8-10 72.9-30.1l246.3-245.7 11.2 11.1c3.1 3.1 8.2 3.1 11.3 0l34-33.9c3.1-3 3.1-8.1 0-11.2zM318 256H161l148-147.7 78.5 78.3L318 256z"&gt;&lt;/path&gt;&lt;/svg&gt; **Practice philosophy**:] Being a scientist practitioner.]

--

.large[.orange[&lt;svg viewBox="0 0 640 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M256 336h-.02c0-16.18 1.34-8.73-85.05-181.51-17.65-35.29-68.19-35.36-85.87 0C-2.06 328.75.02 320.33.02 336H0c0 44.18 57.31 80 128 80s128-35.82 128-80zM128 176l72 144H56l72-144zm511.98 160c0-16.18 1.34-8.73-85.05-181.51-17.65-35.29-68.19-35.36-85.87 0-87.12 174.26-85.04 165.84-85.04 181.51H384c0 44.18 57.31 80 128 80s128-35.82 128-80h-.02zM440 320l72-144 72 144H440zm88 128H352V153.25c23.51-10.29 41.16-31.48 46.39-57.25H528c8.84 0 16-7.16 16-16V48c0-8.84-7.16-16-16-16H383.64C369.04 12.68 346.09 0 320 0s-49.04 12.68-63.64 32H112c-8.84 0-16 7.16-16 16v32c0 8.84 7.16 16 16 16h129.61c5.23 25.76 22.87 46.96 46.39 57.25V448H112c-8.84 0-16 7.16-16 16v32c0 8.84 7.16 16 16 16h416c8.84 0 16-7.16 16-16v-32c0-8.84-7.16-16-16-16z"&gt;&lt;/path&gt;&lt;/svg&gt; **Accountability and evaluation:**] Being a effective practitioner and auditing your work.]

--

.large[.pink[&lt;svg viewBox="0 0 576 512" style="position:relative;display:inline-block;top:.1em;fill:var(--my-blue);height:1em;" xmlns="http://www.w3.org/2000/svg"&gt;  &lt;path d="M542.22 32.05c-54.8 3.11-163.72 14.43-230.96 55.59-4.64 2.84-7.27 7.89-7.27 13.17v363.87c0 11.55 12.63 18.85 23.28 13.49 69.18-34.82 169.23-44.32 218.7-46.92 16.89-.89 30.02-14.43 30.02-30.66V62.75c.01-17.71-15.35-31.74-33.77-30.7zM264.73 87.64C197.5 46.48 88.58 35.17 33.78 32.05 15.36 31.01 0 45.04 0 62.75V400.6c0 16.24 13.13 29.78 30.02 30.66 49.49 2.6 149.59 12.11 218.77 46.95 10.62 5.35 23.21-1.94 23.21-13.46V100.63c0-5.29-2.62-10.14-7.27-12.99z"&gt;&lt;/path&gt;&lt;/svg&gt; **Education and training:**] Learning SCED skills for the rest of your career]

---
# Status of SCED as a research tool? 

.pull-left-narrow[&lt;img src="https://i.vimeocdn.com/portrait/6782840_640x640" alt="Girl in a jacket" width="200" height="150"&gt;

&lt;img src="https://pbs.twimg.com/media/E5lYBTZUYAEJucE?format=png&amp;name=small" alt="Girl in a jacket" width="200" height="150"&gt;]

.pull-right-wide[
+ Highly .blue[accessible] for clinicians.
+ Growing .blue[popularity].
  + Single case texts/books regularly published.
  + No longer restricted to ABA.
  + Health user movements.
+ Appropriate for novel or .blue[emerging] areas.
  + e.g. CBT and panic/psychosis rooted in SCED evidence.
  + RCTs are not the only option.
+ Rapidly developing field.
  + New analytical methods + designs.]


---
background-image: url(https://johnlewis.scene7.com/is/image/JohnLewis/237518072)
background-position: -20% 30%
background-size: 600px 600px

.pull-right-wide[
# Hour Glass Model

Three stage research cycle for evidencing treatment (Salkovskis, 1995):
1. Practice based pilot studies on small *n* in routine services.
2. Highly controlled trials efficacy studies (e.g. RCTs).
3. Implementation studies (return treatment to routine settings.)

.center[
&lt;img src="https://www.babcp.com/portals/0/Images/Members/Picture2.png?ver=2021-03-11-165551-763" alt="Girl in a jacket" width="600" height="265"&gt;
&lt;figcaption class="caption"&gt;Figure taken from interesting
&lt;a href="https://bpspsychub.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/papt.12278"&gt;BABCP article&lt;/a&gt;
&lt;/figcaption&gt;

]

]


---
background-image: url(https://www.its.ws/PublishingImages/Quality/Quality-data.jpg)
background-position:100% 65%
background-size: 45% 65%
#  Clinical Practice

.pull-left[
+ Accountability and evaluation.
+ Demonstrating treatment effectiveness.
+ Monitoring progress (or deterioration).
+ Training in single case methods makes more effective practitioners?
+ Referral on following ineffective treatment – you will really know this.
+ Inviting patient to be part of evaluation.
]

---
background-image: url(https://images.unsplash.com/photo-1588600878108-578307a3cc9d?ixid=MnwxMjA3fDB8MHxzZWFyY2h8MTR8fHJlc2VhcmNofGVufDB8fDB8fA%3D%3D&amp;ixlib=rb-1.2.1&amp;auto=format&amp;fit=crop&amp;w=500&amp;q=60)
background-position:85% 85%
background-size: cover
class: center, bottom

##  .my-yellow[.my-hot-blue[Being a Scientific Practitioner]]

---

# Scientific Practitioner

.left[
Most useful contribution of SCED?

Ability to answer questions that are .red[clinically relevant variants on those of evidence-based practice.]]

--

.pull-left[
&lt;figure class="quote"&gt;
  &lt;blockquote&gt;
  .blue[
  .large[
    “Does this evidence-based treatment work for this particular client, who differs in some way from the sample characteristics of the evidence base?".]]
  &lt;figcaption&gt;
&lt;/figure&gt;
]

--

.pull-right[
&lt;img src="https://www.lanternaeducation.com/wp-content/uploads/2017/01/how-does-it-work-meme.jpg" alt="Girl in a jacket" width="380" height="260"&gt;]


---
#  What’s the advantage of SCED? 

.pull-left[
+ Low cost
+ Low infrastructure
+ Small ‘turning circle’
+ Easily adaptable + flexible
+ Collaborative (if done right)
]
--

.pull-right[
.Large[.white[.my-hot-blue[**Available for all clinicians to use!**]]].

.center[
&lt;img src="https://www.worldoffemale.com/wp-content/uploads/2019/04/you-can-do-it-meme-72.jpg" alt="Girl in a jacket" width="480" height="270"&gt;]
]

---
#  Why don’t clinicians use it? 

+ Lack of confidence
+ Lack of knowledge
+ Can be messy in practice.
  + The ideal described in the classic texts on the design seems a far cry from what is possible in the real world.
+ Perception that it is too much for the recipient to handle.
  + &lt;a href="http://www.dgapractice.com/documents/meehl_case_conferences_adapted.pdf"&gt;Theory of Spun Glass&lt;/a&gt; (Meehl, 1973)

---
name: measures-slide
class: center, middle
background-image: url(https://images.unsplash.com/photo-1501516069922-a9982bd6f3bd?ixid=MnwxMjA3fDB8MHxzZWFyY2h8MXx8bWVhc3VyZXxlbnwwfHwwfHw%3D&amp;ixlib=rb-1.2.1&amp;auto=format&amp;fit=crop&amp;w=500&amp;q=60)
background-position:85% 85%
background-size: cover


#  .my-yellow[.my-hot-blue[Approaches to Measurement]]


---
class: center, top, split-three,



.column.bg-main1[.content[
&lt;img style="border-radius: 50%;" src=" " width="150px"/&gt;

### Nomothetic Measures

.fade[Traditional questionnaire approaches used in services.]
]

.my-hot-pink[ 
- Attempts to generalise people.
- Uses objective knowledge.
- Based on data that is categorical or numerical.
]
]

--

.column.bg-main2[.content[
&lt;img style="border-radius: 50%;" src=" " width="150px"/&gt;


### Idiographic Measures

.fade[Unique measures applied in an individualised manner.]
]
.my-hot-green[
- Focuses on recognition of uniqueness.
- Uses subjective experience.
- Based on study of uniqueness at an individual level.
]
]

--

.column.bg-main3[.content[
&lt;img style="border-radius: 50%;" src="" width="150px"/&gt;

### Qualitative Approaches

.fade[Qualitative approaches to assessment (e.g. interviews).]]
.my-hot-red[
- like ideographics, focuses on subjective judgement and experience. 
- Traditional methods: interviews, focus groups, soft outcomes.
]
]

.footnote[.center[
&lt;a href="https://i.ytimg.com/vi/eiCSJL5zOng/maxresdefault.jpg"&gt;Adapted from &lt;/a&gt;
]]
---

#  Ideographic or nomothetic?

&lt;p&gt;SCED seeks to balance focus on nomothetic and idiographic approaches to measurement.&lt;/p&gt;

A funnel approach from nomothetic to idiographic target measures

--

&lt;figure class="quote"&gt;
  &lt;blockquote&gt;.blue[
    “Different but complementary approaches to accumulating a broader base of evidence... So, when asked by clinical trainees, what two outcome measures I would recommend, my response invariably is: one nomothetic and one idiographic".]
  &lt;figcaption&gt;
    &amp;mdash; Barkham, 2016&lt;/cite&gt;  &lt;/figcaption&gt;
&lt;/figure&gt;

--

&lt;p&gt;Nomothetic and ideographic has long tradition within psychotherapy Sheffield University (e.g., Barkham, Stiles, &amp; Shapiro, 1993).&lt;/p&gt;

.footnote[
&lt;a href="https://eprints.whiterose.ac.uk/104190/1/Commentary%20on%20Alves%20and%20Sales%20final%20version.pdf"&gt; Barkham commentary (2017) &lt;/a&gt;
]


---

https://dclinpsych.leeds.ac.uk/wp-content/uploads/sites/26/2019/03/Gary-Latchford-idiographic-day.pdf

#  Time series measurement 

+ .blue[Frequent and systematic measurement] of outcome measures that are key to the maintenance of the clinical problem
+ In essence, you then ask to what extent the observed variation in the measures is consistent with change occurring?
+ The repeated measures provide data on the variation across time in these outcome. With this information the search can begin for the causes of that variation


.center[
&lt;img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS805ImzbghI67DjNetq3iij46BS0YdSuadlg&amp;usqp=CAU" alt="Girl in a jacket" width="900" height=""&gt;
]
---
#  Using nomothetic measures  

+ These are the questionnaires that are 'off the shelf' and often used for pre-post change.
+ Use them:
  + at the start/end of each phase.
  + at the end of follow-up (if you have that in your design).
+ Try to match one the nomothetic measure to the presenting problem
+ Is the measure you are using one of .blue[Effectiveness]
  + General psychological distress (e.g. CORE-OM, SCL-90, BSI, OQ-45, K-10).
  + Disorder specific (e.g. BDI, PHQ-9, GAD-7, YBOCS, IES).
  + Functioning (e.g. WSAS).
+ Supplement with other measures?
  + Process?
  + Assimiliation?
  + Quality of life?
  + Clinician rated?
  
---

#  Choosing a generalisation measure   

+ Whilst the intervention should influence the target of the intervention, an important issue is whether the intervention generalises to other aspects of the client’s life.
	+ These measures are good test of the external validity of your work.
	+ You take these measures (e.g. quality of life) occasionally and often in tandem with the nomothetic outcomes measures.

---

# Qualitative approaches

+ Qualitative approaches can also be profitably applied to the single-case design. The collection of rich, detailed qualitative information throughout the course of treatment can prove useful in helping to rule out alternative hypotheses

---
background-image: url(https://i.imgflip.com/n7kko.jpg)
background-position:95% 65%
background-size: contain
class: inverse

# .my-hot-blue[Setting up ideographic measures]

---

#  Designing idiographic measures: tips  

### What to measure?
- Anything! (anything that matters).
- Design it collaboratively (ask your patient).
- From the start of the first appointment keep your eyes peeled.
- What does the patient, the family, the referrer want?
- Miracle Question...?
- Dont be afraid to offer suggestions or recommendations.

### Types of measure?
+ Could be a cognition, behaviour, affect or interpersonal process.
+ Anchored and scaled effectively – let the client define this.
+ Intensity measures; Frequency measures; Duration measures;

---
#  Designing idiographic measures: tips  

#### When to measure?
+ Daily? More than?

#### Who measures?
+ Can be anyone (doesen't have to be just one person).
+ Patient? Relative? Carer? Staff team?

#### Recording proceadures?
+ Write it down for them?
+ Diary? Excel sheet? Phone 'notes'? Microsoft Forms?

---
#  Baseline requirements

What is a suitable number of measurements (observations) for a baseline?

Some argue that there should be stability (5% variability around mean) before progressing to intervention .red[(Sidman ???)] however this is not always essential (or realistic).

When does the baseline end? (should be at a defined, planned point). A good place may be when providing the formulation (if using one).

**Remember**! Your ideiographic measures go from the start to end of the work.

---
#  Are baseline trends an issue? 

+ A worsening baseline (worsening of symptoms) may represent a temporary change that would dissipate regardless of any intervention.
+ An improving baseline may prevent confidence in saying whether subsequent improvement is due to intervention or natrual remission.
+ Stability also shows its not spontaneous recovery

.blue[Ideally] the baseline should be stable (mean level) with low variability.
Problems arise if baselines display:
( i )	Linear trends:
(ii)	Higher order trends
(iii)	High variability.
Presence of these makes visual or statistical analysis more difficult **(but still possible)**.

---
# Control idiographic measure 

+ These are an idiographic measure, not expected to change due to the intervention
+ If there is change in the target idiographic measures and not the control is shows the intervention working.

---
#  How to engage clients 

+ Not a must do aspect of your work
+ Good rationale
+ Have a relaxed attitude
+ Display interest in their plight
+ Be flexible
+ This is an aspect of your normal practice
+ Encourage reflectivity
+ Keeping an eye on progress
+ Promise feedback

---
layout: false
class: inverse

#  Modelling and role play  

+ Lets decide as a group what the client will be presenting with and in what context

+ What the demonstration and then we can critique it

+ Then you will get to practice in 2s – you both have a go.

---
name: designs-slide
class: inverse, middle, center

# Designs

---
layout: false
class: inverse

.panelset[

.panel[.panel-name[Designs] &lt;!--Front--&gt;

.small[.pull-left-narrow[.white[Numerous SCED designs]
- A = Baseline
- B = Intervention
- A2/W = Withdrawal
- C = Alt. treatment
- FU = Follow up

Important to consider ethics and feasibility.

Design influences strength of validity.
]]

.pull-right-wide[
### .center[Different types of SCED]
&lt;img src="https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/87f59f64-c81a-4771-bd80-ec57c0da4c9a/gr1_lrg.jpg" alt="Girl in a jacket" width="" height=""&gt;]
] 

.panel[.panel-name[A-B] &lt;!--AB--&gt;

.small[
.pull-left-narrow[
- Most basic &amp; accessible.
- Improvement on simple pre-post
- Low validity.
- Quasi-experimental.
- Leaves open many alternative explanations for observed change.
]]

.pull-right-wide[
### .center[Classic A-B Design]

.center[
&lt;img src="AB.png" alt="Girl in a jacket" width="1200" height="350"&gt;]
]

.right[
.small[For examples of studies using AB designs see
&lt;a href="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/F4ED9F2DD6363B66B0C18F6B4A3081B6/S1352465814000411a.pdf/transdiagnostic-cbt-treatment-of-co-morbid-anxiety-and-depression-in-an-older-adult-single-case-experimental-design.pdf"&gt;(Hague, 2015)&lt;/a&gt; or 
&lt;a href="https://eprints.whiterose.ac.uk/174906/3/Effectiveness%20of%20the%20unified%20protocol%20for%20treating%20co-morbid%20health%20anxiety%20and%20depression%20-%20an%20empirical%20case%20study.pdf"&gt;(Gaskell, 2021)&lt;/a&gt;.
]]



] &lt;!--A-B-FU Design--&gt;

.panel[.panel-name[A-B-FU]

.pull-left-narrow[
- Multiple comparisons possible.
- Can assess maintenance of gains.
- stronger than A-B design.
]

.pull-right-wide[
### .center[Integrating a follow-up]

.center[
&lt;img src="Images/ABFU.png" alt="Girl in a jacket" width="1200" height="350"&gt;]
]

.right[
.small[For an example study using an AB follow up design see
&lt;a href="https://www.tandfonline.com/doi/pdf/10.1080/03069885.2021.1929834"&gt;(Kellett, 2021)&lt;/a&gt;.
]]

] &lt;!--A-B-FU Design--&gt;

.panel[.panel-name[A-B-A-B]

.pull-left-narrow[
- Another point.
- Another point.
- Another point.
]

.pull-right-wide[
### .center[Using a withdrawal phase]

.center[
&lt;img src="Images/ABFU.png" alt="Girl in a jacket" width="1200" height="350"&gt;]
]

.right[
.small[For an example study using an ABAB design see
&lt;a href="https://bpspsychub.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/papt.12278"&gt;(Kellett, 2021)&lt;/a&gt;.
]]

] &lt;!--A-B-A-C--&gt;

.panel[.panel-name[A-B-A-C]
.pull-left-narrow[
- Comparing treatment effectiveness.
– Seldom employed in psychotherapy .
]

.pull-right-wide[
### .center[Alternating the treatment]
.center[&lt;img src="Images/ABAC.png" alt="Girl in a jacket" width="1200" height="350"&gt;]]

.right[.small[For an example study using an ABC design see &lt;a href="https://www.cambridge.org/core/services/aop-cambridge-core/content/view/2997836636C01A6766138701F889AB8C/S1352465820000521a.pdf/treatment_of_compulsive_buying_disorder_comparing_the_effectiveness_of_cognitive_behavioural_therapy_with_personcentred_experiential_counselling.pdf"&gt;(Kellett, 2021)&lt;/a&gt;.]]
]
] &lt;!--Panel-Set-End--&gt;

---

# Withdrawl designs and Ethics

Ask - am I being ethical and so are reversals or withdrawals appropriate?
Important to know the methodological features before you start (see the later planning slide)

###  Problems with withdrawal designs  

Non-reversible treatments:
therapeutic instructions (e.g. self-control / management strategies)
CAP/client expectations/interactions;
long-acting pharmacological interventions;
altered environments;
altered staff attitudes.
Carry-over effects between the phases.
Ethical / clinical problems:
Prior agreement with client / staff needed,
Client consent and general ethical issues
Ethics of accountability and evaluation
Relatively brief withdrawal phase and rapid re-instatement of treatment
Problem of client's expectations and adherence to withdrawal
Treatment holidays?

---

#  Threats to validity

1.	History (extraneous concurrent events)
2.	Maturation (spontaneous recovery)
3.	Testing (reactivity and the mere measurement effect)
4.	Instrumentation (reliability)
5.	Multiple intervention problems (can a psychotherapy be withdrawn)?
6.	Instability

---

#  Mini interventions

+ Borkovec and Castonguay (2006) point out, the use of mini-interventions in which circumscribed components of treatment are actively manipulated is an underused research strategy, but one that offers the opportunity to increase our knowledge of basic change mechanisms in psychological treatments.
	+ Separate out the modules on the time series graphs and test for an effect.
	+ Submit the excel sheets as part of the submission showing each module and the scores on the idiographic measures during the phases

---
#  Planning your design

+what to consider; write a plan and take it to supervision  
+ The type of design
	+ The number of sessions in each phase and module
	+ How the phases will be sequenced with the modules
	+ Frequency of the idiographic measures
	+ Frequency of the nomothetic and generalisation measures
	+ Frequency, duration, place and time of sessions
	+ Baseline fidelity (be able to describe in full detail)
	+ Treatment fidelity (how to keep everything the same bar starting treatment).

---
name: stages-slide
class: inverse

#  STAGES TO SCED  

IDENTIFY QUESTION  AND HYPOTHESIS.
SELECT APPROPRIATE DESIGN AND MEASURES.
IDENTIFY MATERIALS  AND RESOURCES.
COLLECT DATA/  SUPERVISE  STUDY.
ANALYSIS.
INTERPRETATION.
COMMUNICATION.
These stages may need to be considered collectively and not in isolation.  For example. The level of communication of findings may determine the level of analysis adopted.

---
#  IDENTIFY CLINICAL QUESTIONS AND HYPOTHESES 

Have you a clear UP formulation in place?
Have you got the books!?
Is the treatment compatible with the therapy as described in the treatment manual?
State the hypotheses clearly!
State any therapeutic predictions clearly!

---
#  IDENTIFY MEASURES	 

What measures are required to assess therapeutic aims and goals?
Ensure measures are suitable for SCED. In practice this usually means observational measures such as time sampling and staff checklists on in-patient wards; daily diaries of symptoms, functioning, problem resolution; regular use of short psychometric questionnaires etc.
Ensure rating scales are unambiguously worded and are anchored and well described.

---

#  IDENTIFY MEASURES	 

Ensure that diaries are well laid out and well presented. Scraps of paper do not value people and are seldom completed!
Try to use a page a day to record ratings - avoid weekly sheets.
Consider using a combination of measures targeted at both symptoms and functioning .
Consider several sources of measurements: client and partner/carer, child and parent,
Consider adding a follow ups phase; A/B-FU design

---
#  MATERIALS AND RESOURCES 

Ensure measures are acceptable/appropriate for client, or staff or carer or partner.
Plan for study to fit into clinical practice: baseline collected across sessions 1-2, intervention starts session 3, 16 sessions of therapy contracted, follow ups at 6 weeks and 6 months?
Ensure adequate resources - staff properly briefed, supervisor aware of coursework (especially to them), new staff on wards are briefed.

---
#  MATERIALS AND RESOURCES 

If staff are collecting the data do they understand the design rationale and do they need any training?
Data is being recorded and stored reliably (i.e. it is being written down in a retrievable manner, it is not missing and is confidential).
If appropriate, staff should receive ongoing feedback about progress of the case (i.e. regular review meetings) and this be reported in the method.
What are the consequences of diverting resources to this project in relation to other ongoing clinical work? Is it feasible in the setting your working in?

---
#  INTERPRETATION	 

What are the main changes or effects?
How do they correspond to predictions?
Are they valid given the design?
What alternative explanations (i.e. threats to validity) are there?
Are the effects reliable or clinical significant? Are they noticeable to therapist, client or others?
Are they generalizable or clinically replicable?
If effects are clinically nonsignificant - what explanations exist?

---
#  COMMUNICATION  AND DISSEMINATION 

Share the findings with the client or the staff or both.
Thank client and staff.

---
class: inverse

# Course work specific information

---


##  What can you submit?  

+ The design of the submission needs to either be quasi-experimental or a SCED.  The design of quasi-single case experiments is A/B .
	+ It is advantageous but not necessary to have a follow-up phase (i.e. an A/B-FU design) in which the idiographic measures continue to be collected and the nomothetic measure(s) are collected at the final follow-up.
	+ CAPs are also encouraged to consider completing a true SCED in which a cross-over design is used (e.g. A/B/C where B is the UP and C is CAT) or where there is a treatment removal component (i.e. ABA, or ABAB ).
	+ All designs need to be agreed in clinical supervision, and treatment withdrawal particularly considered due to the associated ethical issues.

---
#  How to do a good piece of coursework 

The structure is (4,000 words):
Title
Introduction, aims and hypotheses
Methods
Results
Discussion
References
Appendices (not in the word count)

---
#  Reporting standards for SCED  

+ Look in the resource pack and its there! (SCRIBE guidelines)
	+ This will help you write inclusively.
	+ Read this before planning a case too!

---
#  What goes in the introduction?  

+ Concise summary of relevant background literature about the UP and how it relates to the case.
	+ Consider and refer to relevant NICE guidance if available.
	+ Provide focus of present case study briefly mentioning rationale and approach and end with specification of hypotheses according to design.

---
#  How to write the methods  

+ Outline of rationale and design of SCED, brief and confidential description of client ( presenting problem/diagnosis/previous service usage/current medication ), service, supervision, and your details.
	+ Describe the idiographic measures and the data collection methods (e.g. observational schedules, self-monitoring diaries completed by the client ) and the analysis strategy being used and naming the package being used.
	+ List and provide evidence of the psychometric properties of nomothetic measures used and the analysis strategy being taken (e.g. RCSC).
	+ A three-column treatment adherence table should be provided detailing the session number, UP module, clinical content of that session.
	+ Report any competency checks done by your supervisor.

---


&lt;table class="table" style="font-size: 18px; margin-left: auto; margin-right: auto;"&gt;
 &lt;thead&gt;
  &lt;tr&gt;
   &lt;th style="text-align:left;"&gt; Session &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Phase of study and module &lt;/th&gt;
   &lt;th style="text-align:left;"&gt; Content &lt;/th&gt;
  &lt;/tr&gt;
 &lt;/thead&gt;
&lt;tbody&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Session 1 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; A: Baseline &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Assessment of current functioning &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Session 2 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; A: Baseline &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Assessment of developmental history and formulation produced &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Session 3 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; B: Module 1; motivation enhancement &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Balance sheet and goals &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Session 4 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; B: Module 2; understanding emotions &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Completed 3 system analysis and agreed homework &lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
   &lt;td style="text-align:left;"&gt; Sessions 5 and 6 &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; B: Module 3;  emotion awareness &lt;/td&gt;
   &lt;td style="text-align:left;"&gt; Completed and analysed two ARCs and agreed homework &lt;/td&gt;
  &lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;

---
#  What goes in the results?  

+ Present the idiographic results first in the form of time series graphs for each measure that show each of the phases of the study. Days not sessions on the horizontal axis and scores on the vertical axis.
	+ A baseline median trend line should be fitted and also trend lines fitted for each phase. 
	+ Baseline phases should be assessed for trend using both visual analysis and statistical analysis (e.g. Tau).  When significant baseline trend arises, statistical analyses which adjust for baseline trend should be employed (e.g. Tau-U).  Individual study phases should also be assessed for serial dependency (autocorrelation).
	+ Present a table of means (SD) for each idiographic measure for each phase of the study.

---
#  What goes in the results?  

+ Idiographic outcome measures should be assessed for between phase change using a minimum of three nonoverlap tests (e.g. PND, PEM, PAND, NAP, IRD).  These findings should be reported in a table and interpreted using the established guidelines. 
	+ The scores on nomothetic measure(s) should be presented in a table for each time point.
	+ This table also contains reliable and clinical change analysis and also the relevant clinical and community norms on that measure.
	+ If there is a sessional nomothetic outcome measure then that should be graphed at each session.

---
#  What goes in the results?  

+ Additional or supplementary data and graphs can be appended to the report after the reference section.
	+ When statistical analyses are reported, ensure sufficient details ( t values, d.f . , means and SDs of groups, etc.) for their interpretation are provided.
+ Graphs within the body of the text should be of a high standard of presentation and clearly labelled.

---
#  What goes in the discussion?   

+ The findings should be discussed in relation to the original hypotheses.
	+ Please ensure that you relate the results obtained to the design employed.
	+ Consider the generalisability of the intervention effect.
	+ A critical review of the methods, design and analysis employed should be presented.
	+ Please comment on any relevant organisational and ethical issues surrounding this clinical study.  The clinical significance of the study should also be addressed.

---
#  What goes in the appendices?   

+ UP formulation
	+ Examples of the idiographic data collection tools (e.g. observational schedules by staff or patient daily diaries) should be placed in the appendices and care should be taken to ensure that they are anonymous.  Redact personal information.
	+ As the UP is a modularised approach, the CAP trainees should also submit an excel sheet in which the idiographic measures are clearly labelled in terms of dates of completion by the service user and the progression through the UP modules.
	+ The signed consent form

---
#  CONCLUSIONS 

SCED can be used in a wide variety of situations and these range across service users and settings.
CAPs as a scientist-practitioners – a good place to be.
Integrate the methods into your practice – don’t be anxious.
Always start with the baseline -  the design can evolve and be flexible
Remember to reme m ber your client -  your job is to help then and not manipulate variables and phases
Play around with the methodology

---
#  How to analyse and interpret SCED data? 


---
#  Recap from Day 1 

+ Introduced rationale and applications of SCED
	+ Aware of different types of SCED design
	+ How to design and implement measures

---
#  Treatment  

+ Involves introducing (/or withdrawing) an intervention and monitoring change in outcome.
+ The treatment you deliver needs to be well specified
	+ Take all of this – the design and the intervention to supervision.
	+ Tape a treatment session and get your supervisor to rate your clinical competency with the CTS-R and you can report that in your method – that would add to the write up (but isn’t a must do).
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script>var slideshow = remark.create({
"ratio": "16:9",
"slideNumberFormat": "<div class=\"progress-bar-container\">\n  <div class=\"progress-bar\" style=\"width: calc(%current% / %total% * 100%);\">\n  </div>\n</div>`\n",
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
